Australia markets closed

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
21.27+0.20 (+0.95%)
At close: 01:00PM EST
21.37 +0.10 (+0.47%)
After hours: 03:07PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts7577
Avg. Estimate-0.84-0.88-2.74-2.96
Low estimate-0.92-1.05-3.41-3.47
High estimate-0.79-0.74-2.59-2.32
Year ago EPS-0.25-0.97-1.24-2.74
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts7577
Avg. Estimate36.73M36.25M135.34M168.64M
Low estimate34.6M34.8M133.5M158.2M
High estimate38.5M37.44M137.2M181.18M
Year ago sales25.04M26.85M94.08M135.34M
Sales growth (year/est)46.70%35.00%43.80%24.60%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.47-0.71-0.76-0.88
Actual EPS-0.25-0.97-0.06-0.77
Difference0.22-0.260.70.11
Surprise %46.80%-36.60%92.10%12.50%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.84-0.88-2.74-2.96
7 days ago-0.84-0.88-2.74-2.96
30 days ago-0.91-0.95-2.92-3.2
60 days ago-0.9-0.95-2.91-3.2
90 days ago-0.9-0.96-2.91-3.25
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days6465
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCSTLIndustrySector(s)S&P 500
Current qtr.-236.00%N/AN/AN/A
Next qtr.9.30%N/AN/AN/A
Current year-121.00%N/AN/AN/A
Next year-8.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A